CAS 100021-05-4

Levonorgestrel EP Impurity P

CAS: 100021-05-4

Fórmula: C₂₁H₂₈O₂

Peso molecular: 312.45

Ref: ST-EA-CP-L19016

Levonorgestrel EP Impurity P

CAS: 100021-05-4

Fórmula: C₂₁H₂₈O₂

Cor e Forma: White To Off-White Solid

Peso molecular: 312.45

Ref: 4Z-L-2210

5(6)-Dehydro-4(5)-dihydro D-(-)-Norgestrel (>90%)

Produto Controlado

CAS: 100021-05-4

Impurity Levonorgestrel EP Impurity P
Applications 5(6)-Dehydro-4(5)-dihydro D-(-)-Norgestrel (Levonorgestrel EP Impurity P) is a Norgestrel (N689500) impurity.

Fórmula: C₂₁H₂₈O₂

Pureza: >90%

Cor e Forma: Neat

Peso molecular: 312.45

Ref: TR-D229935

Levonorgestrel EP Impurity P

CAS: 100021-05-4

Soluble in Chloroform & in Methanol Confirmed
Insoluble in Wate

Pureza: 90% min

Cor e Forma: Off White or Beige Solid

Peso molecular: 312.45

Ref: ML-LNG16

Vitamin A EP Impurity C

CAS: 100021-05-4

Soluble in Chloroform & in Methanol Confirmed
Insoluble in Wate

Pureza: 90% min

Cor e Forma: Off White or Beige Solid

Peso molecular: 312.45

Ref: ML-VTA03

(17a)-13-Ethyl-17-hydroxy-18,19-dinorpregn-5-en-20-yn-3-one

Produto Controlado

CAS: 100021-05-4

(17a)-13-Ethyl-17-hydroxy-18,19-dinorpregn-5-en-20-yn-3-one is a progestin that acts as an inhibitor of the P450 enzyme. It has been used in the treatment of women with fertility problems. (17a)-13-Ethyl-17-hydroxy-18,19-dinorpregn-5-en--20--yn--3--one has shown inhibitory effects on voltage dependent calcium channels and thus may have contraceptive properties. It has also been shown to be effective in the long term treatment of intrauterine devices. Low bioavailability is a disadvantage of this drug.br>br>

Fórmula: C₂₁H₂₈O₂

Pureza: Min. 95%

Cor e Forma: Powder

Peso molecular: 312.45 g/mol

Ref: 3D-FE20961